GlassScriptPhysician profile
Gennadiy Ivanov
NPI 1861720815
$2,741.53
in general payments reported to CMS, 2019-2025
11 companies · $416 in 2025
The $416 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,243 · 2020: $103 · 2021: $297 · 2022: $82.19 · 2023: $231 · 2024: $369 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $982.63 | 2019 | |
| Abbvie INC. | $638.18 | 2019-2022 | |
| Astellas Pharma US INC | $356.11 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $265.23 | 2023-2025 | |
| Exeltis, USA INC. | $207.42 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $151.55 | 2024-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $51.30 | 2021 | |
| Shield Therapeutics INC | $38.60 | 2023 | Accrufer |
| Lumenis, INC | $18.79 | 2021 | |
| Hologic Sales and Service, LLC | $16.58 | 2025 | Thinprep 2000 Processor, Aptima |
| Renovia INC | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gennadiy Ivanov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.